AERIE PHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued from Q4 2012 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Aerie Pharmaceuticals Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q3 2022.
  • Aerie Pharmaceuticals Inc Common Stock, Shares, Issued for the quarter ending September 30, 2022 was 49.4M shares, a 4.69% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 49.4M +2.21M +4.69% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 48.7M +1.69M +3.6% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 48.6M +1.74M +3.72% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 48.4M +1.62M +3.47% Dec 31, 2021 10-Q 2022-11-04
Q3 2021 47.2M +351K +0.75% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 47M +481K +1.03% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 46.9M +418K +0.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 46.8M +357K +0.77% Dec 31, 2020 10-K 2022-02-25
Q3 2020 46.8M +829K +1.8% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 46.5M +564K +1.23% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 46.5M +554K +1.21% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 46.5M +986K +2.17% Dec 31, 2019 10-K 2021-02-26
Q3 2019 46M +548K +1.21% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 45.9M +6.11M +15.3% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 45.9M +6.42M +16.2% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 45.5M +8.53M +23.1% Dec 31, 2018 10-K 2020-02-24
Q3 2018 45.5M +9.02M +24.8% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 39.8M +3.5M +9.64% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 39.5M +5.87M +17.4% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 36.9M +3.49M +10.4% Dec 31, 2017 10-K 2019-03-01
Q3 2017 36.4M +3.05M +9.14% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 36.3M +9.69M +36.4% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 33.6M +7.12M +26.8% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 33.5M +7M +26.5% Dec 31, 2016 10-K 2018-03-01
Q3 2016 33.4M +7.09M +27% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 26.6M +1.15M +4.51% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 26.5M +1.24M +4.92% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 26.5M +2.44M +10.2% Dec 31, 2015 10-K 2017-03-09
Q3 2015 26.3M +2.32M +9.69% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 25.5M +1.63M +6.84% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 25.3M +1.95M +8.35% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 24M +733K +3.15% Dec 31, 2014 10-K 2016-03-02
Q3 2014 24M +22.9M +2247% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 23.9M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 23.3M Mar 31, 2014 10-Q 2014-05-13
Q4 2013 23.3M +22.3M +2313% Dec 31, 2013 10-K 2015-02-27
Q3 2013 1.02M Sep 30, 2013 10-Q 2013-12-05
Q4 2012 965K Dec 31, 2012 10-K 2014-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.